Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western amazon region of Brazil

[1]  J. M. Villalobos-Salcedo,et al.  Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western amazon region of Brazil , 2014, Virology Journal.

[2]  S. Alavian,et al.  Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. , 2013, Annals of hepatology.

[3]  S. Chakrabarti,et al.  Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. , 2012, Annals of hepatology.

[4]  F. Zoulim,et al.  Variability in the Precore and Core Promoter Regions of HBV Strains in Morocco: Characterization and Impact on Liver Disease Progression , 2012, PloS one.

[5]  K. Chatterjee.  An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening , 2012, Journal of laboratory physicians.

[6]  U. Protzer,et al.  Immune Control of Hepatitis B Virus , 2011, Digestive Diseases.

[7]  C. Lee,et al.  A probable case of transfusion‐transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV‐infected donor with negative ID‐NAT , 2010, Transfusion medicine.

[8]  A. Hatzakis,et al.  Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA , 2010, Virology Journal.

[9]  J. Allain,et al.  Transfusion-transmitted hepatitis B virus infection. , 2009, Journal of hepatology.

[10]  S. Mondello,et al.  Occult hepatitis B virus in liver tissue of individuals without hepatic disease. , 2008, Journal of hepatology.

[11]  S. Datta,et al.  Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  Ding‐Shinn Chen,et al.  Kinetics of hepatitis B virus reactivation after chemotherapy: more questions than answers. , 2006, Gastroenterology.

[13]  W. Carman,et al.  Contamination with PCR detectable virus in a virus isolation quality assurance panel. , 2006, Journal of virological methods.

[14]  K. Lole,et al.  Quantitation of hepatitis B virus DNA by real-time PCR using internal amplification control and dual TaqMan MGB probes. , 2006, Journal of virological methods.

[15]  C. Fang.  Blood screening for HBV DNA. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  Ding‐Shinn Chen,et al.  Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  C. Ronsin,et al.  Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan Hepatitis B Virus (HBV) Quantitative Test and Comparison to the VERSANT HBV DNA 3.0 Assay , 2006, Journal of Clinical Microbiology.

[18]  S. Arya,et al.  Hepatitis B vaccination of health care workers in Saudi Arabia. , 2005, American journal of infection control.

[19]  K. Nishioka,et al.  Hepatitis B NAT virus‐positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA , 2005 .

[20]  K. Nishioka,et al.  HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. , 2005, Vox sanguinis.

[21]  S. Glynn,et al.  Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti‐HBc: implications for future HBV screening policy , 2004, Transfusion.

[22]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[23]  Marcia J. Weiss.  Beware! Uncle Sam has Your DNA: Legal Fallout from its Use and Misuse in the U.S. , 2004, Ethics and Information Technology.

[24]  J. Allain,et al.  Occult hepatitis B virus infection: implications in transfusion , 2004, Vox sanguinis.

[25]  D. Paraskevis,et al.  Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. , 2002, Journal of virological methods.

[26]  A. Nitsche,et al.  Real-time PCR in virology. , 2002, Nucleic acids research.

[27]  C. Foy,et al.  Emerging homogeneous DNA-based technologies in the clinical laboratory. , 2001, Clinical chemistry.

[28]  H. Doerr,et al.  The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  J. Saldanha,et al.  Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  R. D. de Man,et al.  Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays , 2000, Journal of Clinical Microbiology.

[31]  J. Pawlotsky,et al.  Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. , 2000, Journal of virological methods.

[32]  Anders Hedrum,et al.  Automated Quantitative Analysis of Hepatitis B Virus DNA by Using the Cobas Amplicor HBV Monitor Test , 1999, Journal of Clinical Microbiology.

[33]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[34]  L. Wang,et al.  Virology Journal , 1966, Nature.